Orion Properties (ONL): The Kawa Fund nominates five directors in advance notice, launching proxy push.
November 18, 2025 · 1 min read
Neuphoria Therapeutics (NEUP): Lynx1 nominates Doberstein & Smith, demands record-date reset and independent directors.
November 18, 2025 · 4 min read
Neuphoria Therapeutics (NEUP): Lynx1 withdraws $5.20 bid, blasts dilutive ATM issuances.
November 18, 2025 · 4 min read
Tiptree Inc. (TIPT): Veradace Partners LP uses investor presentation to question board oversight and push for strategic change
November 17, 2025 · 1 min read
Tiptree Inc. (TIPT): Veradace Partners LP challenges strategy in new presentation, pressing for governance and capital allocation improvements
November 17, 2025 · 1 min read
Silver Star Properties (SLVS): Hartman urges immediate board resignations, warns of pledged assets and liquidity risk
November 17, 2025 · 2 min read
Silver Star Properties (SLVS): Hartman Shareholder Alliance accuses board of “value destruction” after court denies meeting delay
November 17, 2025 · 2 min read
Matthews International (MATW) Faces Renewed Activist Push as Barington Capital Seeks Board Changes and Strategic Overhaul
November 17, 2025 · 4 min read
Barington Capital Pressures Matthews International (MATW) on Strategy, Debt, and CEO Performance in Intensifying Governance Fight
November 17, 2025 · 3 min read
Shah Capital Urges Sale of Novavax (NVAX) After Criticizing Strategy, Dilution, and Vaccine Rollout Missteps
November 12, 2025 · 3 min read
Novavax (NVAX): Shah Capital Slams Leadership Over Market Share Collapse, Costs, and Governance Failures
November 12, 2025 · 3 min read
Carronade Capital Targets Cannae Holdings (CNNE) With Campaign for Board Refresh and Strategic Shift to Unlock NAV Discount
November 10, 2025 · 1 min read
Cannae Holdings (CNNE): Carronade Capital Pushes for Board Overhaul and Governance Reform to Reverse Value Destruction
November 10, 2025 · 1 min read
DOMA Perpetual Capital Pressures Pacira (PCRX) to Hire Bankers as Activist Blasts Spending, Dilution, and Governance Failures
November 10, 2025 · 6 min read
Pacira (PCRX): DOMA Perpetual Capital Demands Immediate Sale Process Citing Overspending and Severe Underperformance
November 10, 2025 · 5 min read